Hematology/Oncology

Top Story

Brachytherapy alone can control intermediate-risk prostate cancer

Brachytherapy alone can control intermediate-risk prostate cancer
September 27, 2016

Read the Perspective from Colleen Lawton, MD, FASTRO

The addition of external beam therapy to brachytherapy did not significantly extend PFS among men with intermediate-risk prostate cancer, according to the initial report of a phase 3 study presented at the ASTRO Annual Meeting.

Thus, radiation treatment with brachytherapy alone may provide adequate cancer control for this population, resulting in fewer long-term adverse events, results showed.

Meeting News Coverage

Adoption of stereotactic body radiation therapy improves OS in elderly patients with NSCLC

September 27, 2016
The widespread adoption of stereotactic body radiation therapy to treat elderly patients with early-stage non–small cell lung cancer has improved survival rates…

BRAF/MEK inhibitor combination extends PFS in melanoma

September 27, 2016
A phase 3 study designed to evaluate combined BRAF and MEK inhibition in patients with BRAF–mutant advanced, unresectable or metastatic melanoma met its primary…
Meeting News Coverage

Postoperative stereotactic radiosurgery improves local control of brain metastases

September 27, 2016
Stereotactic radiosurgery provided better local control than observation in patients with resected brain metastases, according to randomized study results presented at…
In the Journals

Black men who smoke, drink have high risk for esophageal squamous cell carcinoma

September 27, 2016
Black men who have ever smoked tobacco and drank alcohol have the highest incidence of esophageal squamous cell carcinoma compared with other races and women, according…
More News Headlines »
CME Video

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by an educational grant from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty five percent of lung cancers are non-small…
More »
Video
Meeting News Coverage

VIDEO: Crenolanib, venetoclax demonstrate ‘very exciting’ results in AML

August 21, 2016
More »
Featured
At Issue: Breast Cancer Resource Center

At Issue: Breast Cancer Resource Center

CME

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan
morganatic-roan